[1] Pickett MW, Waterstram-Rich K and Turner LW. The future of medicine technology:Are we ready for advanced practice?[J]. J Nucl Med Technol, 2001, 28:280-286.
[2] Hara T, Kosaka N and Kishi H. Development of 18F-fluo-roethylcholine for cancer imaging with PET:Synthesis, biochemistry, and prostate cancer imaging[J]. J Nucl Med, 2002, 43(2):187-199.
[3] Keppler JS, Conti PS. A cost analysis of positron emission tomography[J]. Am J Roentgenol, 2001, 177(1):31-40.
[4] Strijckmans K.The isochronous cyclotron:principles and recent developments[J]. Comput Med Imaging Graph,2000, 25(2):69-78.
[5] Mccarthy TJ, Welch MJ. The state of positron emitting radionuclide production in 1997[J]. Semin Nucl Med, 1998,28(3):235-246.
[6] Link JM, Krohn KA, Clark JC. Production of [11C]CH3I by single pass reaction of [11C]CH4 with I2[J]. Nucl Med Biol,1997, 24(1):93-97.
[7] Firouzbakht ML, Schlyer DJ, Wolf AP, et al. Mechanism of nitrogen-13-1abelled ammonia formation in a cryogenic water target[J]. Nucl Med Biol, 1999, 26(4):437-441.
[8] Agostini D, Iida H, Takahashi A, et al. Regional myocardial metabolic rate of oxygen measured by O2-15 inhalation and positron emission tomography in patients with cardiomyopathy[J]. Clin Nucl Med, 2001, 26(1):41-49.
[9] Votaw JR, Henry TR, Shoup TM, et al. Butanol is superior to water for performing positron emission tomography activation studies[J]. J Cereb Blood Flow Metab, 1999, 19(9):982-989.
[10] Guillaume M, Luxen A, Nebeling B, et al. Recommendations for fluorine-18 production[J]. Appl Radiat Isot, 1992, 42:749-762.
[11] Bishop A, Satyamurthy N, Bida G, et al. Metals suitable for fluorine gas target bodies:first use of aluminum for the production of [18F]F2[J]. Nucl Med Biol, 1996, 23(3):181-188.
[12] Bida GT, Ehrenkaufer RL, Wolf AP, et al. The effect of target-gas purity on the chemical form of F-18 during 18F-F2 produvtion using the neon/fluorine target[J]. J Nucl Med,1980, 21(8):758-762.
[13] Bishop A, Satyamurthy N, Bida G, et al. Proton irradiation of [18O]O2:production of [18F]F2 and [18F]F2+[18F]OF2[J]. Nucl Med Biol, 1996, 23(3):189-199.
[14] Toorongian SA, Mulholland GK, Jeweet DM, et al. Routine production of 2-deoxy-2-[18F]fluoro-D-glucose by direct nucleophilic exchange on quaternary 4-aminopyridinium resin[J]. Nucl Med Biol, 1990, 17(3):273-279.
[15] Mock BH, Winkle W and Vavrek MT. A color spot test for the detection of Kryptofix 2.2.2 in[18F]FDG preparations[J]. Nucl Med Biol, 1997, 24(2):193-195.